A Review on: Cotard’s Syndrome

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    FEEBA P,

  1. Lecturer, Department of Mental Health Nursing Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka, India

Abstract

Cotard’s Syndrome is a rare and severe mental health condition characterized by nihilistic delusions, in which individuals firmly believe that they are dead, no longer exist, or that parts of their body are decaying or missing. These beliefs are not symbolic or metaphorical but are experienced as absolute truths, making the disorder particularly distressing and difficult to manage. The syndrome is most commonly observed in association with major depressive disorder, anxiety disorders, and psychotic illnesses, and it often presents with profound emotional withdrawal, hopelessness, and a distorted sense of self. Although the exact cause of Cotard’s Syndrome remains unclear, research suggests that it arises from a complex interaction between psychiatric and neurological factors. The condition has been linked to brain injuries, epilepsy, stroke, brain tumors, and neurodegenerative disorders, as well as severe mood disorders such as psychotic depression. Abnormal functioning in brain regions involved in emotional processing, self-awareness, and reality testing is thought to contribute to the development of the syndrome. Psychological stress and trauma may further exacerbate symptoms in vulnerable individuals. Diagnosis is primarily clinical and based on careful evaluation of the patient’s symptoms, beliefs, and mental state. Neuroimaging techniques such as MRI or CT scans are often used to identify or rule out underlying neurological abnormalities that may be contributing to the condition. A thorough medical and psychiatric assessment is essential to ensure accurate diagnosis and appropriate treatment planning. Management of Cotard’s Syndrome typically requires a multidisciplinary approach. Pharmacological treatment often includes antipsychotic medications, antidepressants, and antianxiety agents to address psychotic features and mood disturbances. In severe or treatment-resistant cases, electroconvulsive therapy (ECT) has been shown to be highly effective. Supportive measures such as rehydration, nutritional support, and discontinuation of offending medications are crucial, especially when dehydration or drug-induced psychosis plays a role. Psychotherapeutic interventions, including cognitive-behavioral therapy and supportive counseling, help patients cope with their experiences and gradually reconnect with reality. Early diagnosis and timely intervention significantly improve prognosis and quality of life for individuals affected by this challenging disorder.

Keywords: Cognitive Behavioral Therapy, Electroconvulsive Therapy, Medication-induced Psychosis, Nihilistic Delusion, and Psychotic Features

How to cite this article:
FEEBA P. A Review on: Cotard’s Syndrome. Recent Trends in Infectious Diseases. 2026; 03(01):-.
How to cite this URL:
FEEBA P. A Review on: Cotard’s Syndrome. Recent Trends in Infectious Diseases. 2026; 03(01):-. Available from: https://journals.stmjournals.com/rtid/article=2026/view=238405


References

  1. Debruyne H, Portzky M, Van den Eynde F, Audenaert K. Cotard’s syndrome: a review of the literature. Psychopathology. 2009;42(5):312–318.
  2. David AS, Fleminger S, editors. The Oxford handbook of neuropsychiatry. Oxford: Oxford University Press; 2017.
  3. Berrios GE, Luque R. Cotard’s syndrome: analysis of 100 cases. Acta Psychiatr Scand. 1995;91(3):185-188. doi:10.1111/j.1600-0447.1995.tb09764.x
  4. Debruyne H, Portzky M, Van den Eynde F, Audenaert K. Cotard’s syndrome: a case report and review of the literature. Eur Psychiatry. 2009;24(3):163–166.
  5. Ghaffar O, Staines GL. Neuroimaging studies in Cotard’s syndrome. J Neuropsychiatry Clin Neurosci. 2017;29(2):148–153.
  6. Lerner V, Witztum E. Cotard’s syndrome and the neurobiological basis of depressive symptoms. J Clin Psychopharmacol. 2017;37(3):341–344.
  7. Pearn J, Gardner-Thorpe C. Cotard’s syndrome. Aust N Z J Psychiatry. 2002;36(1):110–111. doi:10.1046/j.1440-1614.2002.00981.x
  8. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1977.
  9. Foa EB, Hembree EA, Rothbaum BO. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences. Oxford: Oxford University Press; 2007.
  10. Cotard J. Du délire des négations. Arch Neurol. 1880;4:152-170.
  11. Ramachandran VS, Blakeslee S. Phantoms in the brain: probing the mysteries of the human mind. New York: William Morrow; 1998.
  12. Young AW, Leafhead KM. Betwixt life and death: case studies of the Cotard delusion. In: Halligan PW, Marshall JC, editors. Method in madness: case studies in cognitive neuropsychiatry. Hove (UK): Psychology Press; 1996. p. 147–171.
Ahead of Print Subscription Review Article
Volume 03
01
Received 09/09/2025
Accepted 22/01/2026
Published 31/01/2026
Publication Time 144 Days
55

Login


My IP

PlumX Metrics